Company registration number 15395139 (England and Wales)
WEARSIDE HEALTHCARE SERVICES LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 JANUARY 2025
PAGES FOR FILING WITH REGISTRAR
WEARSIDE HEALTHCARE SERVICES LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 4
WEARSIDE HEALTHCARE SERVICES LIMITED
BALANCE SHEET
AS AT
31 JANUARY 2025
31 January 2025
- 1 -
2025
Notes
£
£
Fixed assets
Investments
3
200,000
Current assets
Debtors
4
25
Cash at bank and in hand
9
34
Creditors: amounts falling due within one year
5
(203,109)
Net current liabilities
(203,075)
Net liabilities
(3,075)
Capital and reserves
Called up share capital
6
100
Profit and loss reserves
(3,175)
Total equity
(3,075)

For the financial period ended 31 January 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved and signed by the director and authorised for issue on 24 September 2025
Dr F Khalil
Director
Company registration number 15395139 (England and Wales)
WEARSIDE HEALTHCARE SERVICES LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 JANUARY 2025
- 2 -
1
Accounting policies
Company information

Wearside Healthcare Services Limited is a private company limited by shares incorporated in England and Wales. The registered office is C/O RMT Accountants & Business Advisors Ltd, Gosforth Park Avenue, Newcastle upon Tyne, United Kingdom, NE12 8EG.

1.1
Reporting period

The company was incorporated on 8 January 2024 and has prepared a 390 day set of accounts running to 31 January 2025.

1.2
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.3
Fixed asset investments

Interests are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

1.4
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand and deposits held at call with banks.

1.5
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest.

WEARSIDE HEALTHCARE SERVICES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 JANUARY 2025
1
Accounting policies
(Continued)
- 3 -
1.6
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.7
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense.

2
Employees

The average monthly number of persons (including directors) employed by the company during the period was:

2025
Total
1
3
Fixed asset investments
2025
£
Other investments other than loans
200,000
Movements in fixed asset investments
Investments
£
Cost or valuation
At 8 January 2024
-
Additions
200,000
At 31 January 2025
200,000
Carrying amount
At 31 January 2025
200,000
4
Debtors
2025
Amounts falling due within one year:
£
Other debtors
25
WEARSIDE HEALTHCARE SERVICES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 JANUARY 2025
- 4 -
5
Creditors: amounts falling due within one year
2025
£
Other creditors
201,129
Accruals and deferred income
1,980
203,109
6
Called up share capital
2025
Ordinary share capital
£
Issued and fully paid
Ordinary A shares of £1 each
75
Ordinary B shares of £1 each
25
100
7
Related party transactions

The following amounts were outstanding at the reporting end date:

2025
Amounts due to related parties
£
Director
201,129

There are no set terms as to repayment of this balance and no interest accruing thereon.

2025-01-312024-01-08falsefalse24 September 2025CCH SoftwareCCH Accounts Production 2025.200No description of principal activityDr F Khalilfalse153951392024-01-082025-01-31153951392025-01-3115395139core:ShareCapital2025-01-3115395139core:RetainedEarningsAccumulatedLosses2025-01-3115395139core:ShareCapitalOrdinaryShares2025-01-3115395139bus:Director12024-01-082025-01-3115395139core:CurrentFinancialInstruments2025-01-3115395139bus:OrdinaryShareClass12024-01-082025-01-3115395139bus:OrdinaryShareClass22024-01-082025-01-3115395139bus:PrivateLimitedCompanyLtd2024-01-082025-01-3115395139bus:SmallCompaniesRegimeForAccounts2024-01-082025-01-3115395139bus:FRS1022024-01-082025-01-3115395139bus:AuditExemptWithAccountantsReport2024-01-082025-01-3115395139bus:FullAccounts2024-01-082025-01-31xbrli:purexbrli:sharesiso4217:GBP